Table 2.
Antibacterial activity of ARM1 against H. pylori clinical isolates.
| Strains | MIC (μg ml‐1) | ||
|---|---|---|---|
| MTZ | CLR | ARM1 | |
| JIGC00347 | 8 (S) | 2 (R) | 4 |
| JIGC00366 | 16 (R) | 0.06 (S) | 8 |
| JIGC00365 | 4 (S) | 0.032 (S) | 8 |
| YRES723 | 16 (R) | < 0.016 (S) | 8 |
| BYES720 | 16 (R) | 2 (R) | 16 |
| YRES811 | 2 (S) | < 0.016(S) | 8 |
| BYES771D | 16 (R) | 0.5 (S) | 16 |
| YRES00962 | 2 (S) | < 0.016 (S) | 8 |
| YRES731 | 2 (S) | 1 (R) | 8 |
| YRES665 | 16 (R) | 2 (R) | 8 |
| JRES00015 | 16 (R) | 4 (R) | 8 |
| YRES1226D | 32 (R) | 1 (R) | 16 |
| YR9009D | 1 (S) | 1 (R) | 8 |
| BHKS159 | 16 (R) | 2 (R) | 8 |
CLR, clarithromycin; MTZ, metronidazole; R, drug resistant; S, drug sensitive.
Breakpoints are according to EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines.